RE:RE:Get The Point!Q4 2016 until our SP moves? Assuming we file on time (June 30th) priority review would be 6 months from June 30th or December 2015. Standard review is 10 months or April 30th 2016. Your dates are very suspect. I'm sure you'll claim you meant fiscal, even though you demanded clarity from our CEO regarding calendar vs fiscal. Are you suggesting they will go it alone? Certainly a partnership will give us a huge SP boost. A potential suitor taking a run at us could also be a huge catlyst for our SP. As would any US firm taking a position. FDA accepting the submission would he another reason to move the needle. Also you rarely see a stock leading up to decision time that doesnt rally. To say we won't rally until FDA approval is a farce. You and SWINE with the same mantra should bode well for us. Giddy up.